ConductScience.org, home

Paper40904655

Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients.

Moaz IM and 6 others. Clin Exp Hepatol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients. Papers, record 40904655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40904655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients.
PubMed
Journal
Clin Exp Hepatol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moaz IMInas M
2Ghanem SESamar E
3Khalil FOFatma O
4Galbt HAHossam A
5Elbauomy ASAhmed S
6Elmahdy SKShimaa K
7Tahoon MAMarwa A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128983565The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.JAMA Oncol2017https://conductscience.org/library/papers/28983565PubMed
227378258Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study.J Egypt Natl Canc Inst2016https://conductscience.org/library/papers/27378258PubMed
326305067A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.Clin Gastroenterol Hepatol2016https://conductscience.org/library/papers/26305067PubMed
434040703Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis.World J Gastrointest Oncol2021https://conductscience.org/library/papers/34040703PubMed
536685261The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients.Clin Exp Hepatol2022https://conductscience.org/library/papers/36685261PubMed
620175034Current strategy for staging and treatment: the BCLC update and future prospects.Semin Liver Dis2010https://conductscience.org/library/papers/20175034PubMed
730403964Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.Gene2019https://conductscience.org/library/papers/30403964PubMed
830289982PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.Int J Cancer2019https://conductscience.org/library/papers/30289982PubMed
935154526The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients.Arch Med Sci2022https://conductscience.org/library/papers/35154526PubMed
1024531328Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.Nat Genet2014https://conductscience.org/library/papers/24531328PubMed
1128802062Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.Hepatology2018https://conductscience.org/library/papers/28802062PubMed
1236804832
Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis.
Tumour Virus Res2023https://conductscience.org/library/papers/36804832PubMed
1321374666Management of hepatocellular carcinoma: an update.Hepatology2011https://conductscience.org/library/papers/21374666PubMed
1428928439Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.Sci Rep2017https://conductscience.org/library/papers/28928439PubMed
1531752753Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis.BMC Cancer2019https://conductscience.org/library/papers/31752753PubMed
1636353245TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36353245PubMed
1730970190Hepatocellular Carcinoma.N Engl J Med2019https://conductscience.org/library/papers/30970190PubMed
1827038645PNPLA3 gene in liver diseases.J Hepatol2016https://conductscience.org/library/papers/27038645PubMed
1929777749Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies.J Hepatol2018https://conductscience.org/library/papers/29777749PubMed

Download CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PNPLA380339PubTator's text mininghttps://conductscience.org/library/genes/80339NCBI Gene
TM6SF253345PubTator's text mininghttps://conductscience.org/library/genes/53345NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40904655

GET https://conductscience.org/api/papers/v1/40904655/authors